| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
Departments of Pediatrics, Obstetrics, and Reproductive Medicine (P.F., M.T., L.G., G.C., E.P., F.P.) and Human Pathology and Oncology (G.D.F., E.L.), University of Siena, 53100 Siena, Italy; Department of Gynecological Science and Reproductive Medicine, University of Padua School of Medicine (G.A.), 35100 Padua, Italy; and Nuffield Department of Obstetrics and Gynecology, John Radcliffe Hospital, University of Oxford (E.A.L.), Oxford OX3 9DU, United Kingdom
Address all correspondence and requests for reprints to: Dr. Felice Petraglia, Department of Pediatrics, Obstetrics, and Reproductive Medicine, University of Siena, Policlinico Le Scotte, viale Bracci, 53100 Siena, Italy. E-mail: petraglia{at}unisi.it.
Context: Placental urocortin has a role in the cascade of events leading to parturition by stimulating myometrial contractility and placental uterotonins secretion.
Objective: The objective of this study was to evaluate urocortin levels in maternal and fetal [umbilical cord artery (UCA) and vein (UCV)] plasma at term and preterm labor.
Design: The study design was a controlled cross-sectional study performed from November 2003 to June 2004.
Setting: This study was performed at the Division of Obstetrics and Gynecology, University of Siena (Siena, Italy).
Patients: Plasma samples were collected at term in the absence of labor (TNL; n = 27; 39.3 ± 0.1 gestational weeks), at term spontaneous vaginal delivery (TL; n = 24; 40.1 ± 0.2 gestational weeks), and at preterm labor (PTL; n = 19; 32.4 ± 0.4 gestational weeks). Changes in urocortin mRNA expression were also evaluated in placentas collected from TNL (n = 11), TL (n = 11), and PTL (n = 10).
Intervention: Urocortin levels were measured by specific RIA. Changes in placental mRNA expression were determined by real-time quantitative RT-PCR analysis.
Results: Maternal and UCA plasma urocortin levels were significantly (P < 0.0001 for all) higher in TL and PTL than in TNL. Furthermore, UCA concentrations were significantly (P < 0.0001 for all) higher than and correlated with maternal concentrations (TNL: r = 0.45; P < 0.05; TL: r = 0.959; P < 0.0001; PTL: r = 0.7719; P < 0.0001). UCV levels were significantly (P < 0.001) higher in TL and PTL than in TNL and were significantly (P < 0.0001 for all) higher than and significantly (P < 0.0001 for all) correlated with maternal values, but were significantly (P < 0.0001 for all) lower than and correlated with UCA values (TNL: r = 0.9548; P < 0.0001; TL: r = 0.927; P < 0.0001; PTL: r = 0.838; P < 0.0001). Placental urocortin mRNA expression did not differ among TNL, TL, and PTL samples.
Conclusions: Fetal urocortin secretion is increased in term and preterm labor. Whether these changes are a consequence rather than a cause of human parturition remains to be addressed.
This article has been cited by other articles:
![]() |
A. Imperatore, Wei Li, F. Petraglia, and J. R. G. Challis Urocortin 2 Stimulates Estradiol Secretion From Cultured Human Placental Cells: An Effect Mediated by the Type 2 Corticotrophin-releasing Hormone (CRH) Receptor Reproductive Sciences, June 1, 2009; 16(6): 551 - 558. [Abstract] [PDF] |
||||
![]() |
F. M. Severi, C. Boni, L. Bruni, C. Bocchi, R. A. Aguiar, F. M. Reis, and F. Petraglia The Increase of Blood Flow in the Fetal Middle Cerebral Artery Correlates With the Onset of Labor at Term Reproductive Sciences, July 1, 2008; 15(6): 584 - 590. [Abstract] [PDF] |
||||
![]() |
P. Florio, E. A. Linton, M. Torricelli, E. Faldini, F. M. Reis, A. Imperatore, G. Calonaci, E. Picciolini, and F. Petraglia Prediction of Preterm Delivery Based on Maternal Plasma Urocortin J. Clin. Endocrinol. Metab., December 1, 2007; 92(12): 4734 - 4737. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Torricelli, E. Ignacchiti, A. Giovannelli, A. Merola, E. Scarpetti, G. Calonaci, E. Picciolini, P. Florio, F. M Reis, E. A Linton, et al. Maternal plasma corticotrophin-releasing factor and urocortin levels in post-term pregnancies Eur. J. Endocrinol., February 1, 2006; 154(2): 281 - 285. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| Endocrinology | Endocrine Reviews | J. Clin. End. & Metab. |
| Molecular Endocrinology | Recent Prog. Horm. Res. | All Endocrine Journals |